CoChat

Combined Analysis of Concordance between Liquid and Tumor Tissue Biopsies for RAS Mutations in Colorectal Cancer with a Single Metastasis Site: The METABEAM Study

Open access
Kagawa, Yoshinori, Elez, Elena, García-Foncillas, Jesús, Bando, Hideaki, Taniguchi, Hiroya, Vivancos, Ana, Akagi, Kiwamu, García, Ariadna, Denda, Tadamichi, Ros, Javier, Nishina, Tomohiro, Baraibar, Iosune, Komatsu, Yoshito, Ciardiello, Davide, Oki, Eiji, Kudo, Toshihiro, Kato, Takeshi, Yamanaka, Takeharu, Tabernero, Josep, Yoshino, Takayuki · 2021 · Clinical Cancer Research
Cited by 78

The DOI matches its Crossref record; 3 of the 3 references it cites were found in a registry or an index.

Abstract

Purpose: OncoBEAM™ is a circulating tumor DNA (ctDNA) test that uses the BEAMing digital PCR technology. We clarified the association between the baseline tumor burden and discordance in the RAS status by metastatic sites in patients with a single metastatic site. Experimental Design: Data from previous Spanish and Japanese studies investigating the concordance of the RAS status between OncoBEAM™ and tissue biopsy in 221 patients with metastatic colorectal cancer (mCRC) were used. We collected data from patients with liver, peritoneal, or lung metastases and evaluated the concordance rates according to the metastatic site and the association between the concordance rate and tumor burden. Results: Patients had metastases in the liver (n = 151), peritoneum (n = 25), or lung (n = 45) with concordance rates of 91% (95% confidence interval, 85%–95%), 88% (68%–97%), and 64% (49%–78%), respectively. Factors associated with concordance included the baseline longest diameter and lesion number (P = 0.004), and sample collection interval (P = 0.036). Concordance rates ≥90% were observed in the following groups: liver metastases alone, regardless of the baseline longest diameter and lesion number; peritoneal metastases alone in patients with a baseline longest diameter ≥20 mm; and lung metastases alone in patients with a baseline longest diameter ≥20 mm and/or number of lesions ≥10. Conclusions: Plasma ctDNA-based liquid biopsy in patients with mCRC may be useful depending on the metastatic site. The maximum diameter and lesion number should be carefully considered when determining patients' RAS status with only peritoneal or lung metastases.

Overview

The claims and statistics of this paper haven’t been checked yet.

Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.

A few free checks a day · papers already verified open instantly · results are public

Integrity signals

Registry

Crossref · 10.1158/1078-0432.ccr-20-3677

Cites

3 of 3 references verified0 citation errors · 0 not checkable

Statistics

Verification

Claims the paper makes

The claims and statistics of this paper haven’t been checked yet.

Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.

A few free checks a day · papers already verified open instantly · results are public

Self-check

Percentages, sums and reported differences re-computed from the paper’s own numbers.

The self-check needs the paper’s full text.

Citations

Cites

Show all 3 references

Cited by

See all 78

Metadata

Authors
Kagawa, Y., Elez, E., García-Foncillas, J., Bando, H., Taniguchi, H., Vivancos, A., Akagi, K., García, A., Denda, T., Ros, J., Nishina, T., Baraibar, I., Komatsu, Y., Ciardiello, D., Oki, E., Kudo, T., Kato, T., Yamanaka, T., Tabernero, J., & Yoshino, T.
Venue
Clinical Cancer Research
Published
2021-02-18
Volume
27
Issue
9
Pages
2515-2522
ISSN
  • 1078-0432 (ISSN-L)
  • 1557-3265
OpenAlex
W3131118090
Cited by
78
References
3
FWCI
4.24
Type
journal article
Language
en
Open access
bronze

About these checks

Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.

Statistics and arithmetic are recomputed, not judged.

Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.

What counts as a claim ›How we measure confidence ›How we check this ›

Are you an author, or do you see a problem with this page? Request a review

How to cite

Cite CoChat for the checks on this page, and the paper for its own findings.

This page
CoChat. (2026). Citation check: Combined Analysis of Concordance between Liquid and Tumor Tissue Biopsies for RAS Mutations in Colorectal Cancer with a Single Metastasis Site: The METABEAM Study. https://app.cochat.ai/papers/10.1158/1078-0432.ccr-20-3677
The paper
Kagawa, Y., Elez, E., García-Foncillas, J., Bando, H., Taniguchi, H., Vivancos, A., Akagi, K., García, A., Denda, T., Ros, J., Nishina, T., Baraibar, I., Komatsu, Y., Ciardiello, D., Oki, E., Kudo, T., Kato, T., Yamanaka, T., Tabernero, J., & Yoshino, T. (2021). Combined Analysis of Concordance between Liquid and Tumor Tissue Biopsies for RAS Mutations in Colorectal Cancer with a Single Metastasis Site: The METABEAM Study. Clinical Cancer Research. https://doi.org/10.1158/1078-0432.ccr-20-3677

Data sources

Bibliographic data: Semantic Scholar, OpenAlex, Crossref.

Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).

Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.